Page URL:

Genetic markers predict Alzheimer's risk

8 April 2013
Appeared in BioNews 699

Three new genetic markers for Alzheimer's disease (AD) have been identified, pointing to a less well-known mechanism to explain how the disease develops.

The gene variants were uncovered by a team led by researchers from Washington University School of Medicine, USA, who linked biomarkers for AD to genes using information from over 1,200 people. The researchers measured amyloid-beta and tau proteins believed to be associated with AD found in the cerebrospinal fluid between the brain and the spine.

Amyloid-beta proteins, the focus of much of the current genetic research on AD, can stick together to form plaques outside neurons in the brain, while tau proteins tangle up inside the brain cells as the disease progresses. Both the plaques and tangles are prime suspects for the cell death and tissue loss that occurs in AD. After neurons die, their contents end up in cerebrospinal fluid, which makes it possible for researchers to measure them.

After comparing the genes of healthy elderly people with that of patients with AD, the team found that four gene variants were linked to high tau protein levels and a risk of AD, three of which were not previously known to be associated with the disease.

'We measured the tau protein in the cerebrospinal fluid and identified several genes that are related to high levels of tau and also affect risk for Alzheimer's disease', said Alison Goate, professor of genetics in psychiatry and co-author of the paper. 'As far as we're aware, three of these genes have no effect on amyloid-beta, suggesting that they are operating through a completely different pathway'.

The fourth gene the team found, APOE, is well known to the geneticists as it has been linked to AD before, but only via the amyloid-beta proteins. The new study found that APOE also affected levels of tau protein.

'It appears APOE influences risk in more than one way', said Professor Goate. 'Some of the effects are mediated through amyloid-beta and others by tau. That suggests there are at least two ways in which the gene can influence our risk for Alzheimer’s disease'.

The researchers explain that rising tau levels may predict the advancement of AD and the study may open up a new direction for drug development. 'Currently, there are a number of anti-amyloid-beta therapies in clinical trials, but it may be really helpful to have other drugs that target other components of the pathological cascade in Alzheimer's disease', Professor Goate told TIME.

Dr Doug Brown, director of research and development at the Alzheimer's Society, told the BBC that the identification of these new genetic markers may only represent a few of the many variants that may influence AD risk. 'It is important to stress that lifestyle factors also play a role, and research has shown that eating a balanced diet, exercising regularly, not smoking, and getting your blood pressure and cholesterol checked regularly are key ways to reduce your risk of dementia', he said.

The study was published in the journal Neuron.

Early genetic markers of Alzheimer's risk identified
BBC News |  5 April 2013
Genetic markers found to predict Alzheimer's
Fox News |  5 April 2013
Genetic markers ID second Alzheimer’s pathway
Washington University (press release) |  4 April 2013
GWAS of Cerebrospinal Fluid Tau Levels Identifies Risk Variants for Alzheimer’s Disease
Neuron |  4 April 2013
14 November 2016 - by Annabel Slater 
Brain tissue from Alzheimer's disease patients shows reduced expression of nuclear genes coding for mitochondrial function...
18 July 2016 - by Chris Hardy 
A gene variant linked to increased risk of Alzheimer's disease may affect memory and thinking skills in children, a study has found...
7 December 2015 - by Chris Hardy 
Scientists have identified a link between the product of the BRCA1 gene, variants which can cause breast and ovarian cancer, and Alzheimer's disease...
14 September 2015 - by Chris Hardy 
A blood test designed to assess how well somebody is ageing could be used to predict whether or not they are likely to develop certain illnesses, like Alzheimer's disease...
2 February 2015 - by Dr Victoria Burchell 
A genetic variant may not only help some people live longer, but also changes the way their brain ages, a study suggests....
18 February 2013 - by Michelle Downes 
Hormone replacement therapy, used to treat the symptoms of menopause, may play a role in slowing the ageing process in women who carry a certain gene variant, claim scientists...
19 November 2012 - by Helen Brooks 
A single genetic mutation increases the risk of developing Alzheimer’s disease by threefold, say scientists from two independent research groups...
16 July 2012 - by Dr Linda Wijlaars 
A rare genetic mutation, found in about one percent of Icelanders in a recent study, appears to protect against Alzheimer's disease and age-related cognitive decline. It is the first mutation found to act in this way and could be a target for future drug therapy...
18 June 2012 - by Dr Linda Wijlaars 
A gene known to be found in many Alzheimer's patients has been linked to the way insulin is processed in the body. The finding could prove there is a link between Alzheimer's disease and type 2 diabetes, explaining why people with diabetes face a higher risk of developing Alzheimer's....
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions

Syndicate this story - click here to enquire about using this story.